NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
BLINK PHARMACY PLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/28/2024
Trademark type
Combined
Nice classes
35, 44, 45
Filing date
08/27/2020
Registration date
05/28/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2020-02-00
First use in commerce
2020-02-00
Drawing code
3
Owner type
03
Owner location
New York, NY, US
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "BLINK PHARMACY PLUS" with a medicinal capsule forming the "I" in "BLINK".
Holders and representatives
Holders
Blink Health Inc.
Representatives
Robert S. Weisbein FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 35Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Online retail pharmacy services; mail order pharmacy services; health care benefit and prescription hub servicesdetermining and communicating health care benefit price comparison information on behalf of patients and providers; healthcare business administration servicesadministering patient reimbursement programs; business administration of pharmacy reimbursement programs and services; business information management; providing healthcare consulting services in the healthcare field for pharmaceuticalbiotechnology and medical device suppliersbusiness consulting services in the cost and payment management of health care; pharmaceutical cost management services; prescription drug utilization review services; patient relationship management services
Class 44
Providing information to patients in the field of administering medications; providing medical information to patients; patient health care counseling and advice regarding products in the field of prescription drugs; providing medical information in the field of adherence and compliance to prescribed medication dosing regimens
Class 45
Providing patient advocate and case management servicescoordinating the procurement and administration of medication
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/12/2024
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/28/2023
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/23/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/18/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/07/2021
GNSL
LETTER OF SUSPENSION E-MAILED
08/07/2021
CNSL
SUSPENSION LETTER WRITTEN
08/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/29/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/29/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/29/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2020
GNRT
NON-FINAL ACTION E-MAILED
12/30/2020
CNRT
NON-FINAL ACTION WRITTEN
12/30/2020
DOCK
ASSIGNED TO EXAMINER
12/28/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/02/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2020
NWAP
NEW APPLICATION ENTERED
08/31/2020
Continuous trademark protection
Get notified about every new filing that threatens BLINK PHARMACY PLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.